United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
briviact 75mg tablets
ucb pharma ltd - brivaracetam - tablet - 75mg
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
briviact 100mg tablets
ucb pharma ltd - brivaracetam - tablet - 100mg
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
briviact 50mg5ml solution for injection vials
ucb pharma ltd - brivaracetam - solution for injection - 10mg/1ml
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
briviact 10mgml oral solution
ucb pharma ltd - brivaracetam - oral solution - 10mg/1ml
European Union -
Norwegian -
EMA (European Medicines Agency)
briviact (in italy: nubriveo)
ucb pharma sa - brivaracetam - epilepsi - antiepileptics, - briviact er indisert som tilleggsbehandling ved behandling av delvis-utbruddet anfall med eller uten sekundær generalisering hos voksne og unge pasienter fra 16 år med epilepsi.
Brazil -
Portuguese -
ANVISA (Agência Nacional de Vigilância Sanitária)
brivlera
ucb biopharma ltda. - brivaracetam - outros antiepilÉticos
Israel -
Hebrew -
Ministry of Health
בריביאקט 10 מג מל תמיסה להזרקההזלפה
neopharm ltd, israel - brivaracetam - תמיסה להזרקה\אינפוזיה - brivaracetam 10 mg / 1 ml - brivaracetam
Norway -
Norwegian -
Statens legemiddelverk
briviact 25 mg
2care4 aps - brivaracetam - tablett, filmdrasjert - 25 mg
Norway -
Norwegian -
Statens legemiddelverk
briviact 50 mg
2care4 aps - brivaracetam - tablett, filmdrasjert - 50 mg
Norway -
Norwegian -
Statens legemiddelverk
briviact 75 mg
2care4 aps - brivaracetam - tablett, filmdrasjert - 75 mg